Sertraline and Tinzaparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordTinzaparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed sertraline (an antidepressant) along with tinzaparin (a blood thinner given by injection). Both can make it a little easier to bleed. Sertraline affects the way your platelets (the cells that help blood clot) work, and tinzaparin slows down clotting too. Put together, they can add up and raise your chance of bleeding.
Watch for things like nosebleeds, easy bruising, or bleeding that won't stop. This is very manageable. Your care team can keep an eye on you and adjust things as needed, so keep taking both exactly as prescribed and let them know if you notice any unusual bleeding.
Effect: Additive increased bleeding risk when sertraline is combined with tinzaparin (a low-molecular-weight heparin).
Mechanism: This is a pharmacodynamic (not PK) interaction. SSRIs like sertraline deplete platelet serotonin, impairing platelet aggregation and hemostasis; this adds to the anticoagulant effect of tinzaparin. Neither agent is enzyme-dependent for this effect.
- Onset: delayed
- Evidence: probable (case-control and cohort data)
- Severity: major
Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, GI or other hemorrhage). Counsel the patient on bleeding signs. Anticoagulant dose may need individualization; escalate promptly if bleeding occurs.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients that their bleeding risk is elevated.1. Hemostasis depends in part on the release of serotonin from platelets. Studies using case-control and cohort designs have demonstrated that using SSRIs (for example, sertraline) alongside anticoagulants carries an association with a greater bleeding risk 231. Taking sertraline at the same time as an anticoagulant can heighten the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
Both drugs are useful, and this combination can be used safely with attention. Here is how a care team typically handles it:
- Closer monitoring for signs of bleeding while you use both.
- Individualized dosing if your team judges it appropriate; your dose may be adjusted and tailored to you.
- Patient awareness of what to watch for.
What you should do:
- Keep taking both exactly as prescribed unless told otherwise.
- Report nosebleeds, unusual bruising, tiny red skin spots, blood in urine or stool, or any bleeding that won't stop.
- Seek urgent care for heavy or uncontrolled bleeding, and tell your pharmacist or prescriber about all your medicines.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) found a higher risk of clinically relevant bleeding (defined as hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also receiving concurrent SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus an SSRI (n=117) were matched to randomly chosen patients treated with warfarin alone (n=117). The SSRIs used were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes across 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleedings across 586.4 treatment years. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for a first bleeding during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be constrained by prior bleeding events, uncertain patient adherence, and the exclusion from the model of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin 2.
b) A population-based, case-controlled study of patients newly starting coumarins (acenocoumarol and phenprocoumon) together with selective serotonin reuptake inhibitors (SSRIs) found an increased risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also using a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients receiving SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the influence of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or the placebo group; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was checked before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not increase warfarin's anticoagulant effects to a clinically meaningful extent, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Tinzaparin together?
Taking sertraline with the blood thinner tinzaparin can add up to a higher bleeding risk, so watch for bruising or bleeding and report it. Keep taking both as prescribed and let your care team monitor you. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Tinzaparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Tinzaparin interaction managed?
Both drugs are useful, and this combination can be used safely with attention. Here is how a care team typically handles it: Closer monitoring for signs of bleeding while you use both. Individualized dosing if your team judges it appropriate; your dose may be adjusted and tailored to you. Patient awareness of what to watch for. What you should do: Keep taking both exactly as prescribed unless told… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Tinzaparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Tinzaparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist